This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hunziker, J. Articles by Miller, S.C. Search for Related Content PubMed PubMed Citation Articles by Hunziker, J. Articles by Miller, S.C. Social Bookmarking                         What's this?

Mandibular Bone Formation Rates in Aged Ovariectomized Rats Treated with Anti-resorptive Agents Alone and in Combination with Intermittent Parathyroid Hormone

Division of Radiobiology, Department of Radiology, School of Medicine, University of Utah, 729 Arapeen Dr, Salt Lake City, UT 84108-1218

TJ Wronski

Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610

S.C. Miller

Division of Radiobiology, Department of Radiology, School of Medicine, University of Utah, 729 Arapeen Dr, Salt Lake City, UT 84108-1218

Anti-resorptive agents-including estrogen (E), calcitonin (CT), and bisphosphonates-are established in the treatment of osteoporosis. Intermittent administration of parathyroid hormone (PTH) stimulates bone formation and is a possible therapeutic agent for the restoration of bone mass. The purpose was to determine the effects of the anti-resorptive agents alone and in combination with intermittent PTH on bone formation in the mandible and a long bone in the aged ovariectomized (Ovx) rat. Female rats were ovariectomized or sham-operated. One year later, groups of Ovx rats were treated with E, CT, or the bisphosphonate, Risedronate (NE). Additional groups of Ovx rats were treated with each of these agents in combination with human PTH for 10 weeks. Estrogen treatment suppressed most indices of bone formation in the humerus and mandible, while NE decreased some indices of formation at the endocortical and endosteal surfaces of the mandible and humerus. Increased double-labeled surface and mineral apposition rates were observed only on the mandibular endosteal surfaces following CT treatment. When the anti-resorptive agents were combined with intermittent PTH, most indices of bone formation at all skeletal sites were substantially greater than those of the untreated Ovx controls as well as the E-, CT-, and NE-treated groups, respectively. These results provide additional evidence that established and emerging therapies for osteoporosis affect osseous tissues in the oral cavity, and this may influence the progression of diseases and/or aging changes at this site.

Key Words: parathyroid hormone • bisphosphonates • calcitonin • estrogen • bone formation • mandible • rats.

Journal of Dental Research, Vol. 79, No. 6, 1431-1438 (2000)
DOI: 10.1177/00220345000790061301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Liu, J. Guo, L. Wang, N. Chen, A. Karaplis, D. Goltzman, and D. Miao Distinctive anabolic roles of 1,25-dihydroxyvitamin D3 and parathyroid hormone in teeth and mandible versus long bones J. Endocrinol., November 1, 2009; 203(2): 203 - 213. [Abstract] [Full Text] [PDF]